CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- 4 Shares withheld for taxes CEO gave up 4,535 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 23,590 shares (to pay taxes)
- 4 Grant or award CEO acquired 166,000 shares (grant or award)
- 4 Grant or award SVP, CHINA OPERATIONS acquired 29,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 52,000 shares (grant or award)
- 4 Shares withheld for taxes CEO gave up 23,490 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 819 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 16,658 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, China Operations gave up 18,182 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 1,680 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 21,841 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO gave up 819 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,807 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO gave up 1,680 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 1,860 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, China Operations gave up 3,308 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 1,085 shares (to pay taxes)
- 4 Planned sale Director sold 2,000 shares at $1.03 ($2,060)
- 4 Grant or award Chief Financial Officer acquired 120,000 shares (grant or award)
- 4 Grant or award SVP, China Operations acquired 120,000 shares (grant or award)
Page 4 of 38 · 760 filings